553 related articles for article (PubMed ID: 11773413)
1. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
[TBL] [Abstract][Full Text] [Related]
2. Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein.
Castrucci MR; Kawaoka Y
J Virol; 1995 May; 69(5):2725-8. PubMed ID: 7535862
[TBL] [Abstract][Full Text] [Related]
3. Influenza A virus M2 ion channel protein: a structure-function analysis.
Holsinger LJ; Nichani D; Pinto LH; Lamb RA
J Virol; 1994 Mar; 68(3):1551-63. PubMed ID: 7508997
[TBL] [Abstract][Full Text] [Related]
4. Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity.
Watanabe T; Watanabe S; Ito H; Kida H; Kawaoka Y
J Virol; 2001 Jun; 75(12):5656-62. PubMed ID: 11356973
[TBL] [Abstract][Full Text] [Related]
5. Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells.
Wang C; Lamb RA; Pinto LH
Virology; 1994 Nov; 205(1):133-40. PubMed ID: 7526533
[TBL] [Abstract][Full Text] [Related]
6. [Structure and function of the influenza virus M2 ion channel protein].
Sakaguchi T
Nihon Rinsho; 1997 Oct; 55(10):2587-92. PubMed ID: 9360376
[TBL] [Abstract][Full Text] [Related]
7. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
8. Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure.
Sweet TM; Maassab HF; Coelingh K; Herlocher ML
J Virol Methods; 1997 Dec; 69(1-2):103-11. PubMed ID: 9504756
[TBL] [Abstract][Full Text] [Related]
9. Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue.
Wang C; Lamb RA; Pinto LH
Biophys J; 1995 Oct; 69(4):1363-71. PubMed ID: 8534806
[TBL] [Abstract][Full Text] [Related]
10. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
[TBL] [Abstract][Full Text] [Related]
11. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
Tu Q; Pinto LH; Luo G; Shaughnessy MA; Mullaney D; Kurtz S; Krystal M; Lamb RA
J Virol; 1996 Jul; 70(7):4246-52. PubMed ID: 8676445
[TBL] [Abstract][Full Text] [Related]
12. Influenza A virus with defective M2 ion channel activity as a live vaccine.
Watanabe T; Watanabe S; Kida H; Kawaoka Y
Virology; 2002 Aug; 299(2):266-70. PubMed ID: 12202229
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
14. Ion selectivity and activation of the M2 ion channel of influenza virus.
Shimbo K; Brassard DL; Lamb RA; Pinto LH
Biophys J; 1996 Mar; 70(3):1335-46. PubMed ID: 8785289
[TBL] [Abstract][Full Text] [Related]
15. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
Wang C; Takeuchi K; Pinto LH; Lamb RA
J Virol; 1993 Sep; 67(9):5585-94. PubMed ID: 7688826
[TBL] [Abstract][Full Text] [Related]
16. The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging.
McCown MF; Pekosz A
J Virol; 2005 Mar; 79(6):3595-605. PubMed ID: 15731254
[TBL] [Abstract][Full Text] [Related]
17. How to overcome resistance of influenza A viruses against adamantane derivatives.
Scholtissek C; Quack G; Klenk HD; Webster RG
Antiviral Res; 1998 Feb; 37(2):83-95. PubMed ID: 9588841
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
[TBL] [Abstract][Full Text] [Related]
19. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
[TBL] [Abstract][Full Text] [Related]
20. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
